Scott B. Brown, Chief Financial Officer at Tracon Pharmaceuticals, Inc. (TCON), bought 1,000 shares at $3.69 ($4K) on 2021-08-13, disclosed to the SEC on 2021-08-17.
Open-market purchase of $4k TCON by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| TCON | BUY | 2022-03-30 | $3K | — | Filing → |
| TCON | BUY | 2021-03-09 | $8K | — | Filing → |